AF
| |
Atle Fund Management AB13F | |
| Atle Fund Management AB | |
| Last update 2025-07-14 | 37 Stocks (1 new) |
| Value $234.00 Mil | Turnover 10 % |
Atle Fund Management AB Top Holdings of 2025-06-30
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LLY | Eli Lilly and Co | 38,721 | 30,184.2 | +11.90% | 12.920 | +1.37% | 0.000 | -7.94% | +0.34% | 692,791.6 | Drug Manufacturers | |
ABBV | AbbVie Inc | 86,933 | 16,136.5 | -2.57% | 6.910 | -0.21% | 0.000 | +10.35% | +9.44% | 334,309.4 | Drug Manufacturers | |
BSX | Boston Scientific Corp | 126,185 | 13,553.5 | -4.60% | 5.800 | -0.27% | 0.010 | +8.96% | +16.03% | 153,329.8 | Medical Devices & Instruments | |
NBIX | Neurocrine Biosciences Inc | 88,392 | 11,110.0 | +16.49% | 4.750 | +0.67% | 0.090 | +30.22% | -3.28% | 13,065.5 | Drug Manufacturers | |
MRK | Merck & Co Inc | 139,172 | 11,016.9 | +9.00% | 4.710 | +0.39% | 0.010 | +3.54% | -18.12% | 200,782.1 | Drug Manufacturers | |
SYK | Stryker Corp | 27,466 | 10,866.4 | +19.43% | 4.650 | +0.76% | 0.010 | +12.62% | +8.63% | 148,815.0 | Medical Devices & Instruments | |
VRTX | Vertex Pharmaceuticals Inc | 24,328 | 10,830.8 | +6.66% | 4.640 | +0.29% | 0.010 | -5.99% | +14.18% | 118,077.9 | Biotechnology | |
ISRG | Intuitive Surgical Inc | 18,559 | 10,085.1 | +20.94% | 4.320 | +0.75% | 0.010 | +7.43% | -0.64% | 185,882.9 | Medical Devices & Instruments | |
TMO | Thermo Fisher Scientific Inc | 24,266 | 9,838.9 | +6.16% | 4.210 | +0.24% | 0.010 | -2.88% | -20.13% | 156,565.6 | Medical Diagnostics & Research | |
COR | Cencora Inc | 31,466 | 9,435.1 | -0.28% | 4.040 | -0.01% | 0.020 | +2.33% | +30.90% | 56,765.1 | Medical Distribution |
Atle Fund Management AB's Historical Top Holdings Breakdowns
Atle Fund Management AB's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
UNH | UnitedHealth Group Inc | 2025-06-30 | Reduce Reduce | -2.79% | 274.35 ($384.44) 599.47 | $282.65 | -26.48% | Reduce -46.76% | 13,727 | -12,055 | |
LLY | Eli Lilly and Co | 2025-06-30 | Add Add | +1.37% | 713.71 ($777.85) 898.95 | $771.71 | -0.79% | Add 11.9% | 38,721 | 4,119 | |
SYK | Stryker Corp | 2025-06-30 | Add Add | +0.76% | 337.37 ($374.07) 395.63 | $389.40 | 4.10% | Add 19.43% | 27,466 | 4,468 | |
ISRG | Intuitive Surgical Inc | 2025-06-30 | Add Add | +0.75% | 451.58 ($522.44) 565.94 | $518.62 | -0.73% | Add 20.94% | 18,559 | 3,214 | |
NBIX | Neurocrine Biosciences Inc | 2025-06-30 | Add Add | +0.67% | 87.54 ($114.62) 128.18 | $132.02 | 15.18% | Add 16.49% | 88,392 | 12,511 | |
MIRM | Mirum Pharmaceuticals Inc | 2025-06-30 | Add Add | +0.65% | 38.39 ($44.53) 51.11 | $51.93 | 16.62% | Add 38.37% | 106,912 | 29,649 | |
AUTL | Autolus Therapeutics PLC | 2025-06-30 | Add Add | +0.61% | 1.14 ($1.65) 2.35 | $2.41 | 46.06% | Add 130.48% | 1,105,461 | 625,817 | |
IRON | Disc Medicine Inc | 2025-06-30 | New Buy New Buy | +0.56% | 34.28 ($47.01) 55 | $57.77 | 22.89% | New holding | 24,652 | 24,652 | |
MRUS | Merus NV | 2025-06-30 | Add Add | +0.55% | 34.89 ($46.93) 62.42 | $63.26 | 34.80% | Add 69.7% | 59,889 | 24,597 | |
ACLX | Arcellx Inc | 2025-06-30 | Reduce Reduce | -0.53% | 52.8 ($62.31) 68.1 | $67.59 | 8.47% | Reduce -41.74% | 25,732 | -18,439 |
Atle Fund Management AB Total Holding History ($B)
Atle Fund Management AB's Asset Allocation
Atle Fund Management AB Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
Atle Fund Management AB's Hypothetical Growth since 2025-06-30
Atle Fund Management AB's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
Atle Fund Management AB's Holdings Heat Map
Size field:
Atle Fund Management AB's Holdings Bubble Chart
Atle Fund Management AB News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers